This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Roche Molecular Systems, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Kristina Chu in Genetic Engineering
Introduction
Kristina Chu is an accomplished inventor based in Pleasanton, CA (US). She has made significant contributions to the field of genetic engineering, particularly in the development of novel bacteriophage-based technologies. Her work focuses on creating innovative solutions for bacteria-related diseases.
Latest Patents
Kristina holds 1 patent for her invention titled "Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems." This invention relates to compositions and methods for producing genetically engineered bacteriophages, bacteriophage-like particles, and non-replicating transduction particles (NRTPs). These NRTPs contain non-native tail fibers that exhibit altered host specificity and reactivity. The invention also encompasses methods for utilizing these bacteriophages and NRTPs in the development of novel diagnostics, therapeutics, and research reagents for bacteria-related diseases.
Career Highlights
Kristina is currently employed at Roche Molecular Systems, Inc., where she continues to advance her research in genetic engineering. Her work has positioned her as a key figure in the development of innovative solutions for healthcare challenges.
Collaborations
Kristina collaborates with talented professionals in her field, including Barbara Eckert and Arrash Moghaddasi. These collaborations enhance her research and contribute to the advancement of genetic engineering technologies.
Conclusion
Kristina Chu's innovative work in genetic engineering, particularly her patented technologies, showcases her commitment to addressing critical healthcare issues. Her contributions are paving the way for new diagnostic and therapeutic solutions in the fight against bacteria-related diseases.